Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:08 PM UTC
| NCT Number | NCT05128825 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | PHASE2 |
| Target Enrollment | 310 participants |
| Active Locations | 43 sites in the US |
| Sponsor | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc |
| Last Updated on CT.gov | September 29, 2026 (3 weeks ago) |
As of October 21, 2026: Clinical trial NCT05128825 is currently recruiting participants. This phase2 study for ovarian cancer is actively seeking new participants at 43 locations across the United States. The study is sponsored by K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05128825 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 43 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05128825 was last updated 3 weeks ago (September 29, 2026). HelloStudys verifies this status automatically.